Brazil · Investor

Vivo Ventures

Last cheque observed Jul 2026; 50 cheques on record.

Email

Deploying nowNew fund $6.4M, Jan 2012VC firm

Series ASeries BSeries DVenture Capital & Private Equity

Deploying now
50%of best year1cheques in 12 months, 50 on record
Since the last cheque93days00hrs00min00sec
Median round$7.0MRounds led1 of 50Sole investor3 roundsExits7 from the portfolioMostly inUnited States, 93%
Pitch Vivo Ventures

Vivo Ventures highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 46% of its rounds

  3. 03

    Sole investor in 3 rounds, median $30M

  4. 04

    7 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Venture Capital & Private Equity
Based in
Sao Paulo, Brazil
Cold pitches
Not stated

The record

Every round we can evidence, newest first50 appearances

  1. 2026

    1 round

  2. Jul
    InspiraSeries A · BR · LatamList$2.8MWith 1 other
  3. 2024

    2 rounds

  4. Dec
    KlubiSeries A · BR · LatamList$7.0MLed
  5. Oct
    AgrolendSeries C · BR · SP Ventures$53MWith 10 others
  6. 2014

    5 rounds

  7. Oct
    Aclaris TherapeuticsSeries B · US$21MWith 3 others
  8. Sept
    AirXpandersSeries E · US$1.0MWith 3 others
  9. Apr
    ProNAi TherapeuticsSeries D · US$60MWith 8 others
  10. Apr
    Nora TherapeuticsSeries B · US$18MWith 4 others
  11. Apr
    Eiger BioPharmaceuticalsSeries A · US$5.8MWith 1 other
  12. 2013

    4 rounds

  13. Nov
    Ocera TherapeuticsVenture · US · fiercebiotech.com$28MWith 7 others
  14. Jul
    TRIA BeautyGrowth · US · pevc.dowjones.com$46MWith 6 others
  15. Jun
    AirXpandersSeries E · US · t.co$9.0MWith 3 others
  16. Jan
    Carbylan TherapeuticsSeries B · US · altapartners.com$6.0MWith 2 others
  17. 2012

    7 rounds

  18. Oct
    Aclaris TherapeuticsSeries A · US · finsmes.com$21MWith 3 others
  19. Oct
    TRIA BeautyVenture · US$7.5MWith 3 others
  20. Jun
    Ceptaris TherapeuticsSeries D · US · finsmes.com$10MWith 5 others
  21. Jun
    SentreHEARTSeries C · US · finsmes.com$26MWith 2 others
  22. Apr
    AirXpandersSeries D · US$11MWith 4 others
  23. Jan
    AirXpandersSeries D · US · researchviews.com$1.1MWith 2 others
  24. Jan
    AirXpandersGrowth · US$10MWith 4 others
  25. 2011

    7 rounds

  26. Nov
    Medley HealthSeries A · US · sec.gov$20MWith 2 others
  27. Nov
    Medley HealthSeries B · US · finsmes.com$20MWith 2 others
  28. Nov
    Rempex PharmaceuticalsSeries B · US · rempexpharma.com$68MWith 4 others
  29. Aug
    Yaupon TherapeuticsSeries D · US · finsmes.com$14MWith 3 others
  30. Jun
    Revance TherapeuticsSeries D · US · finsmes.com$45MWith 6 others
  31. Feb
    TRIA BeautyVenture · US$26MWith 3 others
  32. Jan
    NextWave PharmaceuticalsSeries C · US · finsmes.com$45MWith 7 others
  33. 2010

    4 rounds

  34. Nov
    Revance TherapeuticsSeries D · US · sec.gov$36MWith 4 others
  35. Sept
    TRIA BeautyVenture · US · finsmes.com$16MWith 3 others
  36. Jun
    Vicept TherapeuticsSeries A · US · vicepttx.com$16MWith 4 others
  37. Jan
    NeomendSeries D · US · finsmes.com$30MWith 4 others
  38. 2009

    2 rounds

  39. Jun
    Sagent PharmaceuticalsSeries A · US · onbiovc.com$30MSole investor
  40. Feb
    Eiger BioPharmaceuticalsSeries A · US · venturebeat.com$8.3MWith 1 other
  41. 2008

    4 rounds

  42. Sept
    APT PharmaceuticalsSeries A · US · aptbio.com$32MWith 6 others
  43. Sept
    Sagent PharmaceuticalsSeries A · US$30MSole investor
  44. Aug
    InteKrinSeries C · US · deals.venturebeat.com$19MWith 6 others
  45. Jul
    TRIA BeautySeries E · US$30MWith 1 other
  46. 2007

    9 rounds

  47. Dec
    Revance TherapeuticsSeries C · US$43MWith 5 others
  48. Nov
    Carbylan TherapeuticsSeries B · US · carbylan.com$20MWith 2 others
  49. Nov
    Yaupon TherapeuticsSeries C · US$15MWith 1 other
  50. Oct
    APT PharmaceuticalsSeries A · US$22MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

ACAlbert ChaA Managing Member of the General PartnersiFiling they signed
EEEdgar EnglemanA Managing Member of the General PartnersiFiling they signed
FKFrank KungA Managing Member of the General PartnersiFiling they signed

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

Eiger BioPharmaceuticalsBought by CelladonUndisclosedNov 2015
Rempex PharmaceuticalsBought by The Medicines Company$464MDec 2013
Ceptaris TherapeuticsBought by Actelion Pharmaceuticals$250MJul 2013
NeomendBought by C. R. Bard$140MOct 2012
NextWave PharmaceuticalsBought by PfizerUndisclosedOct 2012
AgraQuestBought by Bayer - Germany$425MJul 2012
Vicept TherapeuticsBought by Allergan$275MJul 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Vivo Ventures. A count of rooms they were both in, not a relationship either has claimed.

Sofinnova InvestmentsVC firm9rounds togetherTechnology PartnersHedge fund8rounds togetherInterWest PartnersVC firm7rounds togetherAisling CapitalPrivate equity6rounds togetherGBS VenturesVC firm5rounds togetherPalo Alto InvestorsGrowth equity5rounds togetherProlog VenturesVC firm5rounds togetherDe Novo VenturesGrowth equity4rounds togetherEssex Woodlands Healthcare PartnersVC firm4rounds togetherF-Prime CapitalVC firm4rounds togetherFidelity BiosciencesInvestment firm4rounds togetherOrbiMedPrivate equity4rounds together

Recently backed

The latest companies Vivo Ventures put money into.

Inspira$2.8M · Jul 2026Klubi$7.0M · Dec 2024Agrolend$53M · Oct 2024

Quick answers about Vivo Ventures

What does Vivo Ventures invest in?

Vivo Ventures invests most often at Series A and Series B (46% of the rounds on record), in sectors such as Venture Capital & Private Equity.

How active is Vivo Ventures?

50 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Jul 2026.

What has Vivo Ventures invested in recently?

Its most recent investments on record: Inspira (Series A, Jul 2026), Klubi (Series A, Dec 2024) and Agrolend (Series C, Oct 2024).

How big are Vivo Ventures's cheques?

The median round it joins is $7.0M.

Does Vivo Ventures lead rounds?

Sometimes: it led 1 of its 50 investments on record (2%).

Where does Vivo Ventures invest?

Most of the companies it backs are in the United States (93%) and Brazil (8%).

Is Vivo Ventures investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Vivo Ventures invest alongside?

Most often Sofinnova Investments (9 rounds together), Technology Partners (8 rounds together) and InterWest Partners (7 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it